GeminIQ

BHIC

BioScience Health Innovations, Inc.
—

Company Information

Company Name
BioScience Health Innovations, Inc.
CIK
CIK0001784440
Category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Ticker: Exchange
BHIC: OTC
Fiscal Year End
December 31
Owner Organization
06 Technology
SIC
7374
SIC Description
Services-Computer Processing & Data Preparation
Ticker
BHIC

SEC filing data through

Insider Sentiment

Last purchase
—
Last sale
—
Shares purchased (TTM)
0
Shares sold (TTM)
0
Buy ratio (TTM)—

Institutional Sentiment

As of
—
Institutional shares owned
—
Shares outstanding
—
Ownership
—

Earnings Market Reaction

Filing date
2026-08-07
Price on filing date
—
1-month reaction
13.75%
3-month reaction
…
Drift continued0/2 (0%)
Faded / reversed2/2 (100%)
Export data

Balance Sheet

Values in millions ($)
Line item2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-30Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Assets
Cash And Cash Equivalents At Carrying Value111111100000
Accounts Receivable Net Current000000000000
Assets Current
Assets Current222221100000
Income Tax Receivable0-----------
Inventory Net110100000000
Prepaid Expense Current000000000-0-
Other Receivables Net Current0000000---0-
Deferred Income Tax Assets Net000---0-----
Intangible Assets Net Excluding Goodwill00000000--0-
Other Assets
Deposits Assets Noncurrent000---0-----
Other Assets0-----------
Operating Lease Right Of Use Asset000---0-----
Assets Noncurrent-00---0-----
Assets222221100000
Liabilities Current
Accounts Payable Current000000000000
Accrued Liabilities Current00000000000-
Taxes Payable Current000---0-----
Deferred Revenue Current000000000-0-
Notes Payable Current00----------
Liabilities010000000000
Stockholders Equity Deficit
Preferred Stock Value000000000000
Common Stock Value000000000000
Stockholders Equity
Preferred Stock Par Or Stated Value Per Share------0.000.000.000.000.000.00
Stockholders Equity2212211000-00
Additional Paid In Capital221111111100
Retained Earnings Accumulated Deficit-000110-0-0-0-0-0-0
Liabilities And Stockholders Equity222221100000
Preferred Stock Shares Authorized1-----0---0-
Preferred Stock Shares Outstanding000000000000
Preferred Stock Shares Issued000000000000
Common Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.000.00
Common Stock Shares Authorized25025025025075752507575757575
Common Stock Shares Issued121111111111111110101010
Shares Outstanding121111111111111110101010

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

BioScience Health Innovations, Inc. (BHIC) — SEC Financial Statements & Analysis

BioScience Health Innovations, Inc. (BHIC) is a services-computer processing & data preparation company, incorporated in NV. BioScience Health Innovations, Inc. trades on OTC as: BHIC. BioScience Health Innovations, Inc. (BHIC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07. Based on that filing, BioScience Health Innovations, Inc. carries a market cap of $47.50M, a P/E ratio of -72.19x, a P/B ratio of 25.89x, a P/S ratio of 10.58x, an enterprise value of $47.05M, and an EV/EBITDA multiple of -76.73x. On profitability, it posts a gross margin of 53.77%, an operating margin of -13.65%, a net margin of -14.65%, a Return on Equity (ROE) of -37.03%, a Return on Assets (ROA) of -31.39%, and a Return on Invested Capital (ROIC) of -59.17%. Per share, it reports EPS of $-0.06, diluted EPS of $-0.06, free cash flow per share of $-0.13, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 7.77% year-over-year, net income growth of -169.22% year-over-year, and EPS growth of -165.04% year-over-year. On the balance sheet, it maintains free cash flow of $-1.57M (TTM) and net debt of $-451.98K. Figures sourced from SEC EDGAR.

Market Cap
$47.50M
P/E TTM
-72.19x
EPS TTM
$-0.06
P/B TTM
25.89x
ROE TTM
-37.03%
ROA TTM
-31.39%
Free Cash Flow TTM
$-1.57M
Net Revenue TTM Growth 1Y
7.77%

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is BioScience Health Innovations, Inc. in?

BioScience Health Innovations, Inc. (BHIC) operates in the Services-Computer Processing & Data Preparation industry.

What exchange does BHIC trade on?

BioScience Health Innovations, Inc. (BHIC) trades on the OTC.

Where is BioScience Health Innovations, Inc. incorporated?

BioScience Health Innovations, Inc. is incorporated in NV.

When was BioScience Health Innovations, Inc. (BHIC)'s most recent SEC filing?

BioScience Health Innovations, Inc. (BHIC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07.

What is BHIC's market cap?

BioScience Health Innovations, Inc. (BHIC) has a market capitalization of $47.50M as of 2026-06-30.

What is BHIC's EPS (earnings per share)?

BioScience Health Innovations, Inc. (BHIC)'s trailing twelve month EPS is $-0.06 as of 2026-06-30.

What is BHIC's ROE (return on equity)?

BioScience Health Innovations, Inc. (BHIC)'s trailing twelve month Return on Equity (ROE) is -37.03% as of 2026-06-30.

What is BHIC's ROA (return on assets)?

BioScience Health Innovations, Inc. (BHIC)'s trailing twelve month Return on Assets (ROA) is -31.39% as of 2026-06-30.

What is BHIC's ROIC (return on invested capital)?

BioScience Health Innovations, Inc. (BHIC)'s trailing twelve month Return on Invested Capital (ROIC) is -59.17% as of 2026-06-30.

What is BHIC's EV/EBITDA?

BioScience Health Innovations, Inc. (BHIC)'s trailing twelve month EV/EBITDA is -76.73x as of 2026-06-30.

Wall Street's data.
Main Street's price.

Start 7-day free trial